Adult acute lymphoblastic leukaemia in Denmark. A national population-based retrospective study on acute lymphoblastic leukaemia in Denmark 1998-2008. (Q43833498)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 January 2012

Language	Label	Description	Also known as
English	Adult acute lymphoblastic leukaemia in Denmark. A national population-based retrospective study on acute lymphoblastic leukaemia in Denmark 1998-2008.	scientific article published on 11 January 2012

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Adult acute lymphoblastic leukaemia in Denmark. A national population-based retrospective study on acute lymphoblastic leukaemia in Denmark 1998-2008. (English)

1 reference

Europe PubMed Central

27 November 2017

1 reference

based on heuristic

inferred from title

0 references

Kjeld Schmiegelow

2

object named as

Kjeld Schmiegelow

1 reference

Europe PubMed Central

27 November 2017

author name string

Nina Toft

1

1 reference

Europe PubMed Central

27 November 2017

Tobias W Klausen

3

1 reference

Europe PubMed Central

27 November 2017

Henrik Birgens

4

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

11 January 2012

1 reference

Europe PubMed Central

27 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

27 November 2017

157

1 reference

Europe PubMed Central

27 November 2017

97-104

1 reference

Europe PubMed Central

27 November 2017

1

1 reference

Europe PubMed Central

27 November 2017

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Myths and lessons from the adult/pediatric interface in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.09020.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2011.09020.X

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43833498&oldid=2103740771"